Center for Inborn Errors of Immunity, Precision Immunology Institute, Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Nat Rev Genet. 2024 Mar;25(3):184-195. doi: 10.1038/s41576-023-00656-z. Epub 2023 Oct 20.
Inborn errors of immunity (IEIs) are generally considered to be rare monogenic disorders of the immune system that cause immunodeficiency, autoinflammation, autoimmunity, allergy and/or cancer. Here, we discuss evidence that IEIs need not be rare disorders or exclusively affect the immune system. Namely, an increasing number of patients with IEIs present with severe dysregulations of the central nervous, digestive, renal or pulmonary systems. Current challenges in the diagnosis of IEIs that result from the segregated practice of specialized medicine could thus be mitigated, in part, by immunogenetic approaches. Starting with a brief historical overview of IEIs, we then discuss the technological advances that are facilitating the immunogenetic study of IEIs, progress in understanding disease penetrance in IEIs, the expanding universe of IEIs affecting distal organ systems and the future of genetic, biochemical and medical discoveries in this field.
先天性免疫缺陷(IEI)通常被认为是免疫系统罕见的单基因疾病,可导致免疫缺陷、自身炎症、自身免疫、过敏和/或癌症。在这里,我们讨论了这样一种证据,即 IEI 不一定是罕见疾病,也不一定仅影响免疫系统。越来越多的 IEI 患者表现出中枢神经系统、消化系统、肾脏或肺部系统的严重失调。因此,专门医学分科实践导致的 IEI 诊断方面的当前挑战,在一定程度上可以通过免疫遗传学方法加以缓解。我们首先简要回顾了 IEI 的历史,然后讨论了促进 IEI 免疫遗传学研究的技术进步、对 IEI 疾病穿透性的理解进展、影响远端器官系统的 IEI 不断扩大的范围以及该领域在遗传、生化和医学发现方面的未来。